Palisade Bio (PALI) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2025)
Palisade Bio (PALI) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Palisade Bio | 424.57 Mn | 291.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -45.96% |
| Mar 31, 2025 | -42.25% |
| Dec 31, 2024 | -40.74% |
| Sep 30, 2024 | -43.46% |
| Jun 30, 2024 | -42.46% |
| Mar 31, 2024 | -41.92% |
| Dec 31, 2023 | -35.61% |
| Sep 30, 2023 | -37.77% |
| Jun 30, 2023 | -38.79% |
| Mar 31, 2023 | -43.01% |
| Dec 31, 2022 | -43.45% |
| Sep 30, 2022 | -42.81% |
| Jun 30, 2022 | -60.92% |
| Mar 31, 2022 | -61.70% |
| Dec 31, 2021 | -59.33% |
| Sep 30, 2021 | -60.59% |
| Jun 30, 2021 | -61.68% |
| Mar 31, 2021 | -53.61% |
| Dec 31, 2020 | -57.08% |
| Sep 30, 2020 | -46.27% |